PCSA   $2.87  2.50% Market Closed After Close 2.665 -7.14%

Processa Pharmaceuticals, Inc.
Total Cash 2.89M
totalCashPerShare 0.885
EBITDA -11.79M
Total Debt 96.84K
quickRatio 2.372
currentRatio 3.968
Total Revenue
debtToEquity 2.603
Revenue/Share
ROA -1.1311
ROE -2.11713
grossProfits
freeCashflow -5.85M
operatingCashflow -11.12M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 799.02K
forwardPE -0.5283019
floatShares 2.89M
sharesOutstanding 3.27M
sharesShort 163.57K
sharesShortPriorMonth 73.79K
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.09%
heldPercentInstitutions 0.01%
Short Ratio help_outline 1.19%
shortPercentOfFloat 0.05%
impliedSharesOutstanding
bookValue 1.139
Price To Book help_outline 0.98
earningsQuarterlyGrowth
netIncomeToCommon -11.53M
trailingEps -5.25%
forwardEps -2.12%
enterpriseToEbitda -0.07
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.76 4Q 2024
institutionsCount 9
lastUpdated Nov. 7, 2024, 3:25 a.m.